Bioventix PLC banner

Intrinsic Value

The intrinsic value of Bioventix PLC (51B) under the Base Case is EUR per share. Compared with the current market price of 23 EUR, the stock appears .

The intrinsic value is calculated using the DCF method.

Do our valuations actually work? See backtest results .

51B Intrinsic Value

What one share is worth in the bear, base and bull cases.

Create a free account · No card needed

Do our valuations actually work? See backtest results .

Alert me when 51B is below its intrinsic value
Today Hidden ·
51B Valuation History

Intrinsic value next to the price over the past 5 years.

Create a free account · No card needed

Alternatives to 51B

Fundamental Analysis

What Bioventix Does

Biotechnology Health Care

Bioventix makes specialist antibodies that help medical test makers detect tiny amounts of substances in blood. Its main products are sheep-derived monoclonal antibodies used in diagnostic kits for hormones, heart markers, and other clinical tests. The company does not sell tests directly to hospitals; it sells the key biological ingredient that test manufacturers build into their own assays.

Headquarters
United Kingdom UK
Employees
12
IPO date
Apr 29, 2014
Read the full company overview
View Company Overview
Financials
Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Continue 51B Research

Decided on Bioventix? Get an email when 51B reaches the price you’d buy at. Free with an account.

Other Bioventix listings

What is the Intrinsic Value of one 51B stock?

The intrinsic value for Bioventix PLC (51B) under the Base Case is EUR.

Is 51B stock undervalued or overvalued?

Compared with the current market price of 23 EUR, the stock appears .

How reliable are our estimates? See how past valuations played out
Back to Top